An Australian standard of care for Niemann–Pick disease type C
Abstract Background Niemann–Pick disease type C (NP‐C) is the fifth most prevalent lysosomal disorder in Australia. Diagnostic delay is common, impacted by disease heterogeneity, limited awareness within clinical gateway services and exclusion from state‐based newborn screening programmes.
Michel Tchan +23 more
wiley +1 more source
Gingival and Periodontal Diseases and Conditions in Children and Adolescents: Consensus Report
ABSTRACT Background The objectives of this Focused Workshop were to update the epidemiology, aetiology, risk factors, diagnosis and management of gingival and periodontal diseases and conditions in children and adolescents, and to explore the applicability of the 2018 Classification in children and adolescents.
Iain Chapple +30 more
wiley +1 more source
Dual Beneficial Effects of Topical l‐Glutamine on Oral Mucositis in 5‐Fluorouracil‐Treated Mice
ABSTRACT Background Oral mucositis is a severe health and economic problem that occurs in about 40%–90% of patients undergoing cancer treatments. Systemic or topical application of l‐glutamine has been shown to improve mucosal healing and ameliorate oral mucositis (OM) symptoms according to clinical score systems.
Juliana Francisca Grossi Heleno +7 more
wiley +1 more source
Letter to the Editor: 'Rare but relevant: Genetic liver disease in the general medical setting'. [PDF]
McCarron EP.
europepmc +1 more source
Pathogenic mycobacteria achieve cellular persistence by inhibiting the Niemann-Pick Type C disease cellular pathway [version 1; referees: 2 approved, 2 approved with reservations] [PDF]
et al,, Ory, Daniel S
core +1 more source
Advances in Pharmacological Treatments for Cystinosis: Cysteamine and Its Alternatives. [PDF]
Carneiro A, Jones DH.
europepmc +1 more source
Acute Airway Crisis in Mucopolysaccharidosis VI: Management Challenges. [PDF]
Tulebayeva A, Gadepalli C, Sharipova M.
europepmc +1 more source
Cyclodextrins as Modulators of Regulated Cell Death: Implications for Immunometabolism and Therapeutic Innovation. [PDF]
Trasca DM +10 more
europepmc +1 more source

